{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:42:08Z","timestamp":1791186128749,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":200,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642386633","type":"print"},{"value":"9783642386640","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-3-642-38664-0_17","type":"book-chapter","created":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T06:57:23Z","timestamp":1380783443000},"page":"409-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Emerging Molecular Targets for Anti-proliferative Strategies in Pulmonary Arterial Hypertension"],"prefix":"10.1007","author":[{"given":"Ly","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Guignabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,6]]},"reference":[{"issue":"3","key":"17_CR00171","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/01.RES.0000111804.34509.94","volume":"94","author":"K Abe","year":"2004","unstructured":"Abe K, Shimokawa H et al (2004) Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res 94(3):385\u2013393","journal-title":"Circ Res"},{"issue":"9","key":"17_CR00172","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1056\/NEJM199608293350901","volume":"335","author":"L Abenhaim","year":"1996","unstructured":"Abenhaim L, Moride Y et al (1996) Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med 335(9):609\u2013616","journal-title":"N Engl J Med"},{"issue":"2","key":"17_CR00173","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/08977199509028958","volume":"12","author":"SS Arcot","year":"1995","unstructured":"Arcot SS, Fagerland JA et al (1995) Basic fibroblast growth factor alterations during development of monocrotaline-induced pulmonary hypertension in rats. Growth Factors 12(2):121\u2013130","journal-title":"Growth Factors"},{"issue":"5","key":"17_CR00174","doi-asserted-by":"crossref","first-page":"L826","DOI":"10.1152\/ajplung.00199.2002","volume":"284","author":"V Balasubramaniam","year":"2003","unstructured":"Balasubramaniam V, Le Cras TD et al (2003) Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 284(5):L826\u2013L833","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"17_CR00175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1096\/fj.03-0302fje","volume":"18","author":"LM Baudhuin","year":"2004","unstructured":"Baudhuin LM, Jiang Y et al (2004) S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR). FASEB J 18(2):341\u2013343","journal-title":"FASEB J"},{"issue":"12","key":"17_CR00176","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1182\/blood.V81.12.3324.3324","volume":"81","author":"M Benezra","year":"1993","unstructured":"Benezra M, Vlodavsky I et al (1993) Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. Blood 81(12):3324\u20133331","journal-title":"Blood"},{"issue":"4","key":"17_CR00177","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1378\/chest.126.4.1255","volume":"126","author":"JI Benisty","year":"2004","unstructured":"Benisty JI, McLaughlin VV et al (2004) Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension. Chest 126(4):1255\u20131261","journal-title":"Chest"},{"issue":"3","key":"17_CR00178","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1152\/physrev.2001.81.3.999","volume":"81","author":"BC Berk","year":"2001","unstructured":"Berk BC (2001) Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 81(3):999\u20131030","journal-title":"Physiol Rev"},{"issue":"3","key":"17_CR00179","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cardiores.2003.09.015","volume":"60","author":"C Blanpain","year":"2003","unstructured":"Blanpain C, Le Poul E et al (2003) Serotonin 5-HT(2B) receptor loss of function mutation in a patient with fenfluramine-associated primary pulmonary hypertension. Cardiovasc Res 60(3):518\u2013528","journal-title":"Cardiovasc Res"},{"issue":"22","key":"17_CR001710","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1161\/CIRCULATIONAHA.105.609008","volume":"113","author":"S Bonnet","year":"2006","unstructured":"Bonnet S, Michelakis ED et al (2006) An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation 113(22):2630\u20132641","journal-title":"Circulation"},{"issue":"1","key":"17_CR001711","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1471-4159.2007.04542.x","volume":"102","author":"B Brenner","year":"2007","unstructured":"Brenner B, Harney JT et al (2007) Plasma serotonin levels and the platelet serotonin transporter. J Neurochem 102(1):206\u2013215","journal-title":"J Neurochem"},{"issue":"6","key":"17_CR001712","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/hrt.70.6.537","volume":"70","author":"F Brenot","year":"1993","unstructured":"Brenot F, Herve P et al (1993) Primary pulmonary hypertension and fenfluramine use. Br Heart J 70(6):537\u2013541","journal-title":"Br Heart J"},{"issue":"4","key":"17_CR001713","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/BF02524796","volume":"17","author":"J Breuer","year":"1996","unstructured":"Breuer J, Georgaraki A et al (1996) Increased turnover of serotonin in children with pulmonary hypertension secondary to congenital heart disease. Pediatr Cardiol 17(4):214\u2013219","journal-title":"Pediatr Cardiol"},{"issue":"35","key":"17_CR001714","doi-asserted-by":"publisher","first-page":"25167","DOI":"10.1074\/jbc.274.35.25167","volume":"274","author":"JA Buczek-Thomas","year":"1999","unstructured":"Buczek-Thomas JA, Nugent MA (1999) Elastase-mediated release of heparan sulfate proteoglycans from pulmonary fibroblast cultures. A mechanism for basic fibroblast growth factor (bFGF) release and attenuation of bfgf binding following elastase-induced injury. J Biol Chem 274(35):25167\u201325172","journal-title":"J Biol Chem"},{"issue":"2","key":"17_CR001715","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1124\/jpet.105.098269","volume":"317","author":"J Callebert","year":"2006","unstructured":"Callebert J, Esteve JM et al (2006) Evidence for a control of plasma serotonin levels by 5-hydroxytryptamine(2B) receptors in mice. J Pharmacol Exp Ther 317(2):724\u2013731","journal-title":"J Pharmacol Exp Ther"},{"issue":"18","key":"17_CR001716","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1161\/hc4201.097838","volume":"104","author":"AI Campbell","year":"2001","unstructured":"Campbell AI, Zhao Y et al (2001) Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 104(18):2242\u20132248","journal-title":"Circulation"},{"issue":"2","key":"17_CR001717","first-page":"557","volume":"86","author":"G Christ","year":"2001","unstructured":"Christ G, Graf S et al (2001) Impairment of the plasmin activation system in primary pulmonary hypertension: evidence for gender differences. Thromb Haemost 86(2):557\u2013562","journal-title":"Thromb Haemost"},{"issue":"6","key":"17_CR001718","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1165\/ajrcmb.18.6.2980","volume":"18","author":"H Christou","year":"1998","unstructured":"Christou H, Yoshida A et al (1998) Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol 18(6):768\u2013776","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"19","key":"17_CR001719","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1523\/JNEUROSCI.18-19-07869.1998","volume":"18","author":"F Ciccolini","year":"1998","unstructured":"Ciccolini F, Svendsen CN (1998) Fibroblast growth factor 2 (FGF-2) promotes acquisition of epidermal growth factor (EGF) responsiveness in mouse striatal precursor cells: identification of neural precursors responding to both EGF and FGF-2. J Neurosci 18(19):7869\u20137880","journal-title":"J Neurosci"},{"issue":"10","key":"17_CR001720","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1164\/rccm.201103-0412OC","volume":"184","author":"L Ciuclan","year":"2011","unstructured":"Ciuclan L, Bonneau O et al (2011) A novel murine model of severe pulmonary arterial hypertension. Am J Respir Crit Care Med 184(10):1171\u20131182","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"17_CR001721","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/01.RES.0000216858.04599.e1","volume":"98","author":"A Cogolludo","year":"2006","unstructured":"Cogolludo A, Moreno L et al (2006) Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: role of 5-HT2A receptors, caveolin-1, and KV1.5 channel internalization. Circ Res 98(7):931\u2013938","journal-title":"Circ Res"},{"issue":"4","key":"17_CR001722","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S0046-8177(97)90032-0","volume":"28","author":"CD Cool","year":"1997","unstructured":"Cool CD, Kennedy D et al (1997) Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol 28(4):434\u2013442","journal-title":"Hum Pathol"},{"issue":"3","key":"17_CR001723","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20101812","volume":"208","author":"A Courboulin","year":"2011","unstructured":"Courboulin A, Paulin R et al (2011) Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208(3):535\u2013548","journal-title":"J Exp Med"},{"issue":"3","key":"17_CR001724","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1183\/09031936.00084211","volume":"40","author":"A Courboulin","year":"2012","unstructured":"Courboulin A, Barrier M et al (2012) Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH. Eur Respir J 40(3):618\u2013629","journal-title":"Eur Respir J"},{"issue":"10","key":"17_CR001725","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/01.RES.84.10.1223","volume":"84","author":"KN Cowan","year":"1999","unstructured":"Cowan KN, Jones PL et al (1999) Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res 84(10):1223\u20131233","journal-title":"Circ Res"},{"issue":"6","key":"17_CR001726","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/76282","volume":"6","author":"KN Cowan","year":"2000","unstructured":"Cowan KN, Heilbut A et al (2000a) Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 6(6):698\u2013702","journal-title":"Nat Med"},{"issue":"1","key":"17_CR001727","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1172\/JCI6539","volume":"105","author":"KN Cowan","year":"2000","unstructured":"Cowan KN, Jones PL et al (2000b) Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J Clin Invest 105(1):21\u201334","journal-title":"J Clin Invest"},{"issue":"2","key":"17_CR0017200","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1164\/rccm.200811-1682OC","volume":"181","author":"BK Dahal","year":"2010","unstructured":"Dahal BK, Cornitescu T et al (2010) Role of epidermal growth factor inhibition in experimental pulmonary hypertension. Am J Respir Crit Care Med 181(2):158\u2013167","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"17_CR001728","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.molmed.2007.04.002","volume":"13","author":"SG Dann","year":"2007","unstructured":"Dann SG, Selvaraj A et al (2007) mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 13(6):252\u2013259","journal-title":"Trends Mol Med"},{"issue":"8","key":"17_CR001729","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1164\/rccm.201203-0411OC","volume":"186","author":"FS de Man","year":"2012","unstructured":"de Man FS, Tu L et al (2012) Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med 186(8):780\u2013789","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"17_CR001730","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/sj.cdd.4400581","volume":"6","author":"S Dimmeler","year":"1999","unstructured":"Dimmeler S, Zeiher AM (1999) Nitric oxide-an endothelial cell survival factor. Cell Death Differ 6(10):964\u2013968","journal-title":"Cell Death Differ"},{"issue":"3","key":"17_CR001731","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/jcp.21078","volume":"212","author":"W Ding","year":"2007","unstructured":"Ding W, Shi W et al (2007) Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells. J Cell Physiol 212(3):796\u2013806","journal-title":"J Cell Physiol"},{"issue":"2","key":"17_CR001732","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1183\/09031936.03.00038903","volume":"22","author":"P Dorfmuller","year":"2003","unstructured":"Dorfmuller P, Perros F et al (2003) Inflammation in pulmonary arterial hypertension. Eur Respir J 22(2):358\u2013363","journal-title":"Eur Respir J"},{"issue":"6296","key":"17_CR001733","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/bmj.283.6296.881","volume":"283","author":"JG Douglas","year":"1981","unstructured":"Douglas JG, Munro JF et al (1981) Pulmonary hypertension and fenfluramine. Br Med J (Clin Res Ed) 283(6296):881\u2013883","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6","key":"17_CR001734","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1056\/NEJMoa021650","volume":"348","author":"L Du","year":"2003","unstructured":"Du L, Sullivan CC et al (2003) Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med 348(6):500\u2013509","journal-title":"N Engl J Med"},{"issue":"5","key":"17_CR001735","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1183\/09031936.00126010","volume":"37","author":"R Dumitrascu","year":"2011","unstructured":"Dumitrascu R, Kulcke C et al (2011) Terguride ameliorates monocrotaline induced pulmonary hypertension in rats. Eur Respir J 37(5):1104\u20131118","journal-title":"Eur Respir J"},{"issue":"3 Pt 2","key":"17_CR001736","first-page":"H1173","volume":"272","author":"S Eddahibi","year":"1997","unstructured":"Eddahibi S, Raffestin B et al (1997) Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. Am J Physiol 272(3 Pt 2):H1173\u2013H1181","journal-title":"Am J Physiol"},{"issue":"4 Pt 1","key":"17_CR001737","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1164\/ajrccm.157.4.9704095","volume":"157","author":"S Eddahibi","year":"1998","unstructured":"Eddahibi S, Raffestin B et al (1998) Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia. Am J Respir Crit Care Med 157(4 Pt 1):1111\u20131119","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"17_CR001738","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1172\/JCI8678","volume":"105","author":"S Eddahibi","year":"2000","unstructured":"Eddahibi S, Hanoun N et al (2000a) Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 105(11):1555\u20131562","journal-title":"J Clin Invest"},{"issue":"4 Pt 1","key":"17_CR001739","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1164\/ajrccm.162.4.2003124","volume":"162","author":"S Eddahibi","year":"2000","unstructured":"Eddahibi S, Humbert M et al (2000b) Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy. Am J Respir Crit Care Med 162(4 Pt 1):1493\u20131499","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"17_CR001740","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI200112805","volume":"108","author":"S Eddahibi","year":"2001","unstructured":"Eddahibi S, Humbert M et al (2001) Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 108(8):1141\u20131150","journal-title":"J Clin Invest"},{"issue":"3 Suppl","key":"17_CR001741","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1378\/chest.121.3_suppl.97S","volume":"121","author":"S Eddahibi","year":"2002","unstructured":"Eddahibi S, Humbert M et al (2002) Hyperplasia of pulmonary artery smooth muscle cells is causally related to overexpression of the serotonin transporter in primary pulmonary hypertension. Chest 121(3 Suppl):97S\u201398S","journal-title":"Chest"},{"issue":"15","key":"17_CR001742","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1161\/CIRCULATIONAHA.105.591321","volume":"113","author":"S Eddahibi","year":"2006","unstructured":"Eddahibi S, Guignabert C et al (2006) Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. Circulation 113(15):1857\u20131864","journal-title":"Circulation"},{"issue":"4","key":"17_CR001743","doi-asserted-by":"publisher","first-page":"L656","DOI":"10.1152\/ajplung.00090.2003","volume":"287","author":"KA Fagan","year":"2004","unstructured":"Fagan KA, Oka M et al (2004) Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287(4):L656\u2013L664","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"17_CR001744","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00395-007-0674-z","volume":"102","author":"P Fischer","year":"2007","unstructured":"Fischer P, Hilfiker-Kleiner D (2007) Survival pathways in hypertrophy and heart failure: the gp130-STAT axis. Basic Res Cardiol 102(5):393\u2013411","journal-title":"Basic Res Cardiol"},{"issue":"6","key":"17_CR001745","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1083\/jcb.200212060","volume":"162","author":"VC Foletta","year":"2003","unstructured":"Foletta VC, Lim MA et al (2003) Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J Cell Biol 162(6):1089\u20131098","journal-title":"J Cell Biol"},{"issue":"6","key":"17_CR001746","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/j.1552-4604.1995.tb05013.x","volume":"35","author":"WH Frishman","year":"1995","unstructured":"Frishman WH, Huberfeld S et al (1995) Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease. J Clin Pharmacol 35(6):541\u2013572","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"17_CR001747","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cell.2012.02.030","volume":"149","author":"I Garcia-Cao","year":"2012","unstructured":"Garcia-Cao I, Song MS et al (2012) Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell 149(1):49\u201362","journal-title":"Cell"},{"issue":"19","key":"17_CR001748","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1161\/CIRCULATIONAHA.110.973750","volume":"122","author":"G Gary-Bobo","year":"2010","unstructured":"Gary-Bobo G, Houssaini A et al (2010) Effects of HIV protease inhibitors on progression of monocrotaline- and hypoxia-induced pulmonary hypertension in rats. Circulation 122(19):1937\u20131947","journal-title":"Circulation"},{"issue":"2","key":"17_CR001749","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/(SICI)1096-9896(200006)191:2<202::AID-PATH608>3.0.CO;2-D","volume":"191","author":"R Geiger","year":"2000","unstructured":"Geiger R, Berger RM et al (2000) Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease. J Pathol 191(2):202\u2013207","journal-title":"J Pathol"},{"issue":"5","key":"17_CR001750","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1159\/000051082","volume":"38","author":"SJ George","year":"2001","unstructured":"George SJ, Johnson JL et al (2001) Plasmin-mediated fibroblast growth factor-2 mobilisation supports smooth muscle cell proliferation in human saphenous vein. J Vasc Res 38(5):492\u2013501","journal-title":"J Vasc Res"},{"issue":"2","key":"17_CR001751","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1042\/CS20110295","volume":"122","author":"J George","year":"2012","unstructured":"George J, Sun J et al (2012) Transgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice. Clin Sci (Lond) 122(2):83\u201392","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"17_CR001752","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1152\/japplphysiol.00715.2004","volume":"98","author":"EV Gerasimovskaya","year":"2005","unstructured":"Gerasimovskaya EV, Tucker DA et al (2005) Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation. J Appl Physiol 98(2):722\u2013731","journal-title":"J Appl Physiol"},{"issue":"5323","key":"17_CR001753","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1126\/science.277.5323.225","volume":"277","author":"G Giannelli","year":"1997","unstructured":"Giannelli G, Falk-Marzillier J et al (1997) Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277(5323):225\u2013228","journal-title":"Science"},{"issue":"3","key":"17_CR001754","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1091\/mbc.11.3.1023","volume":"11","author":"L Gilboa","year":"2000","unstructured":"Gilboa L, Nohe A et al (2000) Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine\/threonine kinase receptors. Mol Biol Cell 11(3):1023\u20131035","journal-title":"Mol Biol Cell"},{"issue":"5","key":"17_CR001755","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12185-012-1069-y","volume":"95","author":"N Goda","year":"2012","unstructured":"Goda N, Kanai M (2012) Hypoxia-inducible factors and their roles in energy metabolism. Int J Hematol 95(5):457\u2013463","journal-title":"Int J Hematol"},{"issue":"Suppl 2","key":"17_CR001756","first-page":"II11","volume":"17","author":"LM Goncalves","year":"1998","unstructured":"Goncalves LM (1998) Fibroblast growth factor-mediated angiogenesis for the treatment of ischemia. Lessons learned from experimental models and early human experience. Rev Port Cardiol 17(Suppl 2):II11\u2013II20","journal-title":"Rev Port Cardiol"},{"issue":"4","key":"17_CR001757","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1089\/ten.2006.0206","volume":"13","author":"JL Grouf","year":"2007","unstructured":"Grouf JL, Throm AM et al (2007) Differential effects of EGF and TGF-beta1 on fibroblast activity in fibrin-based tissue equivalents. Tissue Eng 13(4):799\u2013807","journal-title":"Tissue Eng"},{"key":"17_CR001758","volume-title":"Pulmonary Hypertension - From Bench Research to Clinical Challenges","author":"Christophe Guignabert","year":"2011","unstructured":"Guignabert C (2011) Interplay between serotonin transporter signaling and voltage-gated potassium channel (Kv) 1.5 expression. In: Sulica R, Preston I (eds) Pulmonary hypertension \u2013 from bench research to clinical challenges. InTech Europe Rijeka, Croatia, pp 49\u201366"},{"issue":"21","key":"17_CR001759","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1161\/CIRCULATIONAHA.104.524926","volume":"111","author":"C Guignabert","year":"2005","unstructured":"Guignabert C, Raffestin B et al (2005) Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation 111(21):2812\u20132819","journal-title":"Circulation"},{"issue":"10","key":"17_CR001760","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/01.RES.0000222546.45372.a0","volume":"98","author":"C Guignabert","year":"2006","unstructured":"Guignabert C, Izikki M et al (2006) Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circ Res 98(10):1323\u20131330","journal-title":"Circ Res"},{"issue":"6","key":"17_CR001761","doi-asserted-by":"publisher","first-page":"L1082","DOI":"10.1152\/ajplung.00199.2009","volume":"297","author":"C Guignabert","year":"2009","unstructured":"Guignabert C, Alvira CM et al (2009a) Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization. Am J Physiol Lung Cell Mol Physiol 297(6):L1082\u2013L1090","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"17_CR001762","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1096\/fj.09-131664","volume":"23","author":"C Guignabert","year":"2009","unstructured":"Guignabert C, Tu L et al (2009b) Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin transporter. FASEB J 23(12):4135\u20134147","journal-title":"FASEB J"},{"issue":"7","key":"17_CR001763","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/sj.bjp.0706408","volume":"146","author":"C Guilluy","year":"2005","unstructured":"Guilluy C, Sauzeau V et al (2005) Inhibition of RhoA\/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension. Br J Pharmacol 146(7):1010\u20131018","journal-title":"Br J Pharmacol"},{"issue":"5","key":"17_CR001764","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1074\/jbc.M604195200","volume":"282","author":"C Guilluy","year":"2007","unstructured":"Guilluy C, Rolli-Derkinderen M et al (2007) Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J Biol Chem 282(5):2918\u20132928","journal-title":"J Biol Chem"},{"issue":"12","key":"17_CR001765","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1164\/rccm.200805-691OC","volume":"179","author":"C Guilluy","year":"2009","unstructured":"Guilluy C, Eddahibi S et al (2009) RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling. Am J Respir Crit Care Med 179(12):1151\u20131158","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"17_CR001766","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/HYPERTENSIONAHA.111.185413","volume":"59","author":"L Guo","year":"2012","unstructured":"Guo L, Qiu Z et al (2012) The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-alpha1C. Hypertension 59(5):1006\u20131013","journal-title":"Hypertension"},{"issue":"2\u20133","key":"17_CR001767","first-page":"160","volume":"27","author":"HP Gurtner","year":"1985","unstructured":"Gurtner HP (1985) Aminorex and pulmonary hypertension. A review. Cor Vasa 27(2\u20133):160\u2013171","journal-title":"Cor Vasa"},{"issue":"35","key":"17_CR001768","doi-asserted-by":"publisher","first-page":"25130","DOI":"10.1074\/jbc.274.35.25130","volume":"274","author":"H He","year":"1999","unstructured":"He H, Venema VJ et al (1999) Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1\/KDR activation of c-Src. J Biol Chem 274(35):25130\u201325135","journal-title":"J Biol Chem"},{"issue":"15","key":"17_CR001769","doi-asserted-by":"publisher","first-page":"8985","DOI":"10.1073\/pnas.95.15.8985","volume":"95","author":"A Herrlich","year":"1998","unstructured":"Herrlich A, Daub H et al (1998) Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. Proc Natl Acad Sci USA 95(15):8985\u20138990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"17_CR001770","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0002-9343(90)90111-P","volume":"89","author":"P Herve","year":"1990","unstructured":"Herve P, Drouet L et al (1990) Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am J Med 89(1):117\u2013120","journal-title":"Am J Med"},{"issue":"3","key":"17_CR001771","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","volume":"99","author":"P Herve","year":"1995","unstructured":"Herve P, Launay JM et al (1995) Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99(3):249\u2013254","journal-title":"Am J Med"},{"issue":"4","key":"17_CR001772","first-page":"497","volume":"27","author":"K Hiramine","year":"2011","unstructured":"Hiramine K, Sata N et al (2011) Hepatocyte growth factor improves the survival of rats with pulmonary arterial hypertension via the amelioration of pulmonary hemodynamics. Int J Mol Med 27(4):497\u2013502","journal-title":"Int J Mol Med"},{"issue":"3","key":"17_CR001773","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.cardiores.2003.09.023","volume":"60","author":"E Hironaka","year":"2003","unstructured":"Hironaka E, Hongo M et al (2003) Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats. Cardiovasc Res 60(3):692\u2013699","journal-title":"Cardiovasc Res"},{"issue":"6","key":"17_CR001774","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1046\/j.1440-1827.2000.01068.x","volume":"50","author":"S Hirose","year":"2000","unstructured":"Hirose S, Hosoda Y et al (2000) Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension. Pathol Int 50(6):472\u2013479","journal-title":"Pathol Int"},{"issue":"4","key":"17_CR001775","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1164\/ajrccm.150.4.7921465","volume":"150","author":"K Huber","year":"1994","unstructured":"Huber K, Beckmann R et al (1994) Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension. Am J Respir Crit Care Med 150(4):929\u2013933","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"17_CR001776","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1183\/09031936.00159911","volume":"40","author":"A Huertas","year":"2012","unstructured":"Huertas A, Tu L et al (2012) Leptin and regulatory T lymphocytes in idiopathic pulmonary arterial hypertension. Eur Respir J 40(4):895\u2013904","journal-title":"Eur Respir J"},{"issue":"5","key":"17_CR001777","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","volume":"151","author":"M Humbert","year":"1995","unstructured":"Humbert M, Monti G et al (1995) Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 151(5):1628\u20131631","journal-title":"Am J Respir Crit Care Med"},{"issue":"12 Suppl S","key":"17_CR001778","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","volume":"43","author":"M Humbert","year":"2004","unstructured":"Humbert M, Morrell NW et al (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):13S\u201324S","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"17_CR001779","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1172\/JCI200419480","volume":"113","author":"M Ieda","year":"2004","unstructured":"Ieda M, Fukuda K et al (2004) Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest 113(6):876\u2013884","journal-title":"J Clin Invest"},{"issue":"4","key":"17_CR001780","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/01.RES.64.4.814","volume":"64","author":"R Ilkiw","year":"1989","unstructured":"Ilkiw R, Todorovich-Hunter L et al (1989) SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats. Circ Res 64(4):814\u2013825","journal-title":"Circ Res"},{"issue":"4","key":"17_CR001781","doi-asserted-by":"publisher","first-page":"L1045","DOI":"10.1152\/ajplung.00082.2007","volume":"293","author":"M Izikki","year":"2007","unstructured":"Izikki M, Hanoun N et al (2007) Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol 293(4):L1045\u2013L1052","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"17_CR001782","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1172\/JCI35070","volume":"119","author":"M Izikki","year":"2009","unstructured":"Izikki M, Guignabert C et al (2009) Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents. J Clin Invest 119(3):512\u2013523","journal-title":"J Clin Invest"},{"issue":"2","key":"17_CR001783","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/toxsci\/kfm171","volume":"99","author":"GC Jiang","year":"2007","unstructured":"Jiang GC, Tidwell K et al (2007) Neurotoxic potential of depleted uranium effects in primary cortical neuron cultures and in Caenorhabditis elegans. Toxicol Sci 99(2):553\u2013565","journal-title":"Toxicol Sci"},{"issue":"6","key":"17_CR001784","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1161\/01.RES.79.6.1131","volume":"79","author":"PL Jones","year":"1996","unstructured":"Jones PL, Rabinovitch M (1996) Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ Res 79(6):1131\u20131142","journal-title":"Circ Res"},{"issue":"4","key":"17_CR001785","first-page":"1349","volume":"150","author":"PL Jones","year":"1997","unstructured":"Jones PL, Cowan KN et al (1997a) Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol 150(4):1349\u20131360","journal-title":"Am J Pathol"},{"issue":"1","key":"17_CR001786","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1083\/jcb.139.1.279","volume":"139","author":"PL Jones","year":"1997","unstructured":"Jones PL, Crack J et al (1997b) Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 139(1):279\u2013293","journal-title":"J Cell Biol"},{"issue":"Pt 4","key":"17_CR001787","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1242\/jcs.112.4.435","volume":"112","author":"PL Jones","year":"1999","unstructured":"Jones PL, Jones FS et al (1999) Induction of vascular smooth muscle cell tenascin-C gene expression by denatured type I collagen is dependent upon a beta3 integrin-mediated mitogen-activated protein kinase pathway and a 122-base pair promoter element. J Cell Sci 112(Pt 4):435\u2013445","journal-title":"J Cell Sci"},{"issue":"11","key":"17_CR001788","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1172\/JCI10259","volume":"106","author":"Y Kasahara","year":"2000","unstructured":"Kasahara Y, Tuder RM et al (2000) Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106(11):1311\u20131319","journal-title":"J Clin Invest"},{"issue":"2","key":"17_CR001789","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/0971-6866.44103","volume":"14","author":"S Katta","year":"2008","unstructured":"Katta S, Vadapalli S et al (2008) t-plasminogen activator inhibitor-1 polymorphism in idiopathic pulmonary arterial hypertension. Indian J Hum Genet 14(2):37\u201340","journal-title":"Indian J Hum Genet"},{"issue":"12","key":"17_CR001790","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/hh2401.100426","volume":"89","author":"A Keegan","year":"2001","unstructured":"Keegan A, Morecroft I et al (2001) Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B\/1D)-receptor antagonist GR127935. Circ Res 89(12):1231\u20131239","journal-title":"Circ Res"},{"issue":"2","key":"17_CR001791","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jcp.1041380207","volume":"138","author":"DJ Kelvin","year":"1989","unstructured":"Kelvin DJ, Simard G et al (1989) FGF and EGF act synergistically to induce proliferation in BC3H1 myoblasts. J Cell Physiol 138(2):267\u2013272","journal-title":"J Cell Physiol"},{"issue":"10","key":"17_CR001792","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1161\/01.ATV.20.10.2233","volume":"20","author":"A Kereveur","year":"2000","unstructured":"Kereveur A, Callebert J et al (2000) High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy. Arterioscler Thromb Vasc Biol 20(10):2233\u20132239","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"17_CR001793","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12016-011-8265-z","volume":"44","author":"N Kherbeck","year":"2013","unstructured":"Kherbeck N, Tamby MC et al (2013) The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension. Clin Rev Allergy Immunol 44(1):31\u201338","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"17_CR001794","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.ajpath.2011.05.051","volume":"179","author":"YM Kim","year":"2011","unstructured":"Kim YM, Haghighat L et al (2011) Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions. Am J Pathol 179(3):1560\u20131572","journal-title":"Am J Pathol"},{"issue":"12","key":"17_CR001795","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1161\/01.RES.0000269828.62250.ab","volume":"100","author":"K Kimura","year":"2007","unstructured":"Kimura K, Ieda M et al (2007) Cardiac sympathetic rejuvenation: a link between nerve function and cardiac hypertrophy. Circ Res 100(12):1755\u20131764","journal-title":"Circ Res"},{"issue":"9","key":"17_CR001796","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.biocel.2008.01.028","volume":"40","author":"FM Kouri","year":"2008","unstructured":"Kouri FM, Queisser MA et al (2008) Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension. Int J Biochem Cell Biol 40(9):1872\u20131882","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"17_CR001797","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4161\/cc.8.3.7555","volume":"8","author":"VP Krymskaya","year":"2009","unstructured":"Krymskaya VP, Goncharova EA (2009) PI3K\/mTORC1 activation in hamartoma syndromes: therapeutic prospects. Cell Cycle 8(3):403\u2013413","journal-title":"Cell Cycle"},{"issue":"6","key":"17_CR001798","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1096\/fj.10-175018","volume":"25","author":"VP Krymskaya","year":"2011","unstructured":"Krymskaya VP, Snow J et al (2011) mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia. FASEB J 25(6):1922\u20131933","journal-title":"FASEB J"},{"issue":"9","key":"17_CR001799","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1161\/CIRCRESAHA.111.257568","volume":"110","author":"G Kwapiszewska","year":"2012","unstructured":"Kwapiszewska G, Markart P et al (2012) PAR-2 inhibition reverses experimental pulmonary hypertension. Circ Res 110(9):1179\u20131191","journal-title":"Circ Res"},{"issue":"Pt 20","key":"17_CR0017100","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122(Pt 20):3589\u20133594","journal-title":"J Cell Sci"},{"issue":"14","key":"17_CR0017101","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/pmic.200600848","volume":"7","author":"S Laudi","year":"2007","unstructured":"Laudi S, Steudel W et al (2007) Comparison of lung proteome profiles in two rodent models of pulmonary arterial hypertension. Proteomics 7(14):2469\u20132478","journal-title":"Proteomics"},{"issue":"10","key":"17_CR0017102","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nm764","volume":"8","author":"JM Launay","year":"2002","unstructured":"Launay JM, Herve P et al (2002) Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 8(10):1129\u20131135","journal-title":"Nat Med"},{"issue":"11","key":"17_CR0017103","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1096\/fj.06-5724com","volume":"20","author":"JM Launay","year":"2006","unstructured":"Launay JM, Schneider B et al (2006) Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells. FASEB J 20(11):1843\u20131854","journal-title":"FASEB J"},{"issue":"3","key":"17_CR0017104","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/01.RES.0000176025.57706.1e","volume":"97","author":"A Lawrie","year":"2005","unstructured":"Lawrie A, Spiekerkoetter E et al (2005) Interdependent serotonin transporter and receptor pathways regulate S100A4\/Mts1, a gene associated with pulmonary vascular disease. Circ Res 97(3):227\u2013235","journal-title":"Circ Res"},{"issue":"5","key":"17_CR0017105","doi-asserted-by":"crossref","first-page":"L1046","DOI":"10.1152\/ajplung.00045.2003","volume":"285","author":"TD Le Cras","year":"2003","unstructured":"Le Cras TD, Hardie WD et al (2003) Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-alpha. Am J Physiol Lung Cell Mol Physiol 285(5):L1046\u2013L1054","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"17_CR0017106","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/emm.2005.4","volume":"37","author":"YS Lee","year":"2005","unstructured":"Lee YS, Byun J et al (2005) Monocrotaline-induced pulmonary hypertension correlates with upregulation of connective tissue growth factor expression in the lung. Exp Mol Med 37(1):27\u201335","journal-title":"Exp Mol Med"},{"issue":"5","key":"17_CR0017107","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1183\/09031936.05.00072504","volume":"25","author":"H Lepetit","year":"2005","unstructured":"Lepetit H, Eddahibi S et al (2005) Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J 25(5):834\u2013842","journal-title":"Eur Respir J"},{"issue":"2","key":"17_CR0017108","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1152\/japplphysiol.00652.2002","volume":"95","author":"P Li","year":"2003","unstructured":"Li P, Oparil S et al (2003) Fibroblast growth factor mediates hypoxia-induced endothelin \u2013 a receptor expression in lung artery smooth muscle cells. J Appl Physiol 95(2):643\u2013651, discussion 863","journal-title":"J Appl Physiol"},{"issue":"6","key":"17_CR0017109","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1161\/01.RES.0000215809.47923.fd","volume":"98","author":"L Long","year":"2006","unstructured":"Long L, MacLean MR et al (2006) Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res 98(6):818\u2013827","journal-title":"Circ Res"},{"issue":"2\u20133","key":"17_CR0017110","first-page":"111","volume":"27","author":"F Loogen","year":"1985","unstructured":"Loogen F, Worth H et al (1985) Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake. Cor Vasa 27(2\u20133):111\u2013124","journal-title":"Cor Vasa"},{"issue":"6","key":"17_CR0017111","doi-asserted-by":"crossref","first-page":"L926","DOI":"10.1152\/ajplung.00247.2002","volume":"284","author":"V Louzier","year":"2003","unstructured":"Louzier V, Raffestin B et al (2003) Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 284(6):L926\u2013L937","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"17_CR0017112","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1172\/JCI57734","volume":"121","author":"W Ma","year":"2011","unstructured":"Ma W, Han W et al (2011) Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease. J Clin Invest 121(11):4548\u20134566","journal-title":"J Clin Invest"},{"issue":"17","key":"17_CR0017113","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1161\/01.CIR.0000127375.56172.92","volume":"109","author":"MR MacLean","year":"2004","unstructured":"MacLean MR, Deuchar GA et al (2004) Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension. Circulation 109(17):2150\u20132155","journal-title":"Circulation"},{"issue":"4","key":"17_CR0017114","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1164\/rccm.200210-1212OC","volume":"168","author":"E Marcos","year":"2003","unstructured":"Marcos E, Adnot S et al (2003) Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. Am J Respir Crit Care Med 168(4):487\u2013493","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"17_CR0017115","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/01.RES.0000126847.27660.69","volume":"94","author":"E Marcos","year":"2004","unstructured":"Marcos E, Fadel E et al (2004) Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res 94(9):1263\u20131270","journal-title":"Circ Res"},{"issue":"6 Suppl","key":"17_CR0017116","doi-asserted-by":"publisher","first-page":"552S","DOI":"10.1378\/chest.128.6_suppl.552S","volume":"128","author":"E Marcos","year":"2005","unstructured":"Marcos E, Fadel E et al (2005) Serotonin transporter and receptors in various forms of human pulmonary hypertension. Chest 128(6 Suppl):552S\u2013553S","journal-title":"Chest"},{"issue":"6 Pt 2","key":"17_CR0017117","first-page":"H1716","volume":"261","author":"K Maruyama","year":"1991","unstructured":"Maruyama K, Ye CL et al (1991) Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity. Am J Physiol 261(6 Pt 2):H1716\u2013H1726","journal-title":"Am J Physiol"},{"issue":"3","key":"17_CR0017118","doi-asserted-by":"publisher","first-page":"L548","DOI":"10.1152\/ajplung.00428.2006","volume":"293","author":"FA Masri","year":"2007","unstructured":"Masri FA, Xu W et al (2007) Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 293(3):L548\u2013L554","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"17_CR0017119","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1161\/01.CIR.0000141576.39579.23","volume":"110","author":"R Mathew","year":"2004","unstructured":"Mathew R, Huang J et al (2004) Disruption of endothelial-cell caveolin-1alpha\/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation 110(11):1499\u20131506","journal-title":"Circulation"},{"issue":"5","key":"17_CR0017120","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.yjmcc.2009.01.015","volume":"46","author":"S Matsunaga","year":"2009","unstructured":"Matsunaga S, Okigaki M et al (2009) Endothelium-targeted overexpression of constitutively active FGF receptor induces cardioprotection in mice myocardial infarction. J Mol Cell Cardiol 46(5):663\u2013673","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"17_CR0017121","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/01.RES.0000145360.16770.9f","volume":"95","author":"MS McMurtry","year":"2004","unstructured":"McMurtry MS, Bonnet S et al (2004) Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res 95(8):830\u2013840","journal-title":"Circ Res"},{"issue":"3","key":"17_CR0017122","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/CIRCULATIONAHA.105.540542","volume":"112","author":"SL Merklinger","year":"2005","unstructured":"Merklinger SL, Jones PL et al (2005) Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension. Circulation 112(3):423\u2013431","journal-title":"Circulation"},{"issue":"2","key":"17_CR0017123","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/hc0202.101974","volume":"105","author":"ED Michelakis","year":"2002","unstructured":"Michelakis ED, McMurtry MS et al (2002) Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels. Circulation 105(2):244\u2013250","journal-title":"Circulation"},{"issue":"1","key":"17_CR0017124","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/thx.54.1.88","volume":"54","author":"Y Mitani","year":"1999","unstructured":"Mitani Y, Ueda M et al (1999) Mast cell chymase in pulmonary hypertension. Thorax 54(1):88\u201390","journal-title":"Thorax"},{"issue":"3","key":"17_CR0017125","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/sj.bjp.0702841","volume":"128","author":"I Morecroft","year":"1999","unstructured":"Morecroft I, Heeley RP et al (1999) 5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor. Br J Pharmacol 128(3):730\u2013734","journal-title":"Br J Pharmacol"},{"issue":"2","key":"17_CR0017126","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1124\/jpet.104.081182","volume":"313","author":"I Morecroft","year":"2005","unstructured":"Morecroft I, Loughlin L et al (2005) Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries. J Pharmacol Exp Ther 313(2):539\u2013548","journal-title":"J Pharmacol Exp Ther"},{"issue":"1 Suppl","key":"17_CR0017127","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","volume":"54","author":"NW Morrell","year":"2009","unstructured":"Morrell NW, Adnot S et al (2009) Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54(1 Suppl):S20\u2013S31","journal-title":"J Am Coll Cardiol"},{"issue":"28","key":"17_CR0017128","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.1038\/sj.onc.1208664","volume":"24","author":"MM Murillo","year":"2005","unstructured":"Murillo MM, del Castillo G et al (2005) Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes. Oncogene 24(28):4580\u20134587","journal-title":"Oncogene"},{"issue":"4","key":"17_CR0017129","doi-asserted-by":"publisher","first-page":"L665","DOI":"10.1152\/ajplung.00050.2003","volume":"287","author":"T Nagaoka","year":"2004","unstructured":"Nagaoka T, Morio Y et al (2004) Rho\/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 287(4):L665\u2013L672","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"17_CR0017130","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1164\/rccm.200405-637OC","volume":"171","author":"T Nagaoka","year":"2005","unstructured":"Nagaoka T, Fagan KA et al (2005) Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Am J Respir Crit Care Med 171(5):494\u2013499","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"17_CR0017131","doi-asserted-by":"publisher","first-page":"a006544","DOI":"10.1101\/cshperspect.a006544","volume":"2","author":"JA Nagy","year":"2012","unstructured":"Nagy JA, Dvorak AM et al (2012) Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harb Perspect Med 2(2):a006544","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"17_CR0017132","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0014-5793(96)00811-3","volume":"392","author":"O Nakagawa","year":"1996","unstructured":"Nakagawa O, Fujisawa K et al (1996) ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine\/threonine kinase in mice. FEBS Lett 392(2):189\u2013193","journal-title":"FEBS Lett"},{"issue":"11","key":"17_CR0017133","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1093\/hmg\/dds073","volume":"21","author":"MT Nasim","year":"2012","unstructured":"Nasim MT, Ogo T et al (2012) BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFbeta-TAK1-MAPK pathways in PAH. Hum Mol Genet 21(11):2548\u20132558","journal-title":"Hum Mol Genet"},{"issue":"4","key":"17_CR0017134","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1378\/chest.10-2588","volume":"140","author":"D Natali","year":"2011","unstructured":"Natali D, Girerd B et al (2011) Pulmonary arterial hypertension in a patient with Cowden syndrome and anorexigen exposure. Chest 140(4):1066\u20131068","journal-title":"Chest"},{"issue":"4","key":"17_CR0017135","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/BF00494064","volume":"82","author":"O Nilsson","year":"1985","unstructured":"Nilsson O, Ericson LE et al (1985) Subcellular localization of serotonin immunoreactivity in rat enterochromaffin cells. Histochemistry 82(4):351\u2013355","journal-title":"Histochemistry"},{"issue":"11","key":"17_CR0017136","first-page":"2357","volume":"26","author":"T Nishimaki","year":"1999","unstructured":"Nishimaki T, Aotsuka S et al (1999) Immunological analysis of pulmonary hypertension in connective tissue diseases. J Rheumatol 26(11):2357\u20132362","journal-title":"J Rheumatol"},{"issue":"9","key":"17_CR0017137","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrcardio.2011.104","volume":"8","author":"DS O\u2019Callaghan","year":"2011","unstructured":"O\u2019Callaghan DS, Savale L et al (2011) Treatment of pulmonary arterial hypertension with targeted therapies. Nat Rev Cardiol 8(9):526\u2013538","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"17_CR0017138","doi-asserted-by":"publisher","first-page":"C405","DOI":"10.1152\/ajpcell.00337.2011","volume":"302","author":"A Ogawa","year":"2012","unstructured":"Ogawa A, Firth AL et al (2012) PDGF enhances store-operated Ca2+ entry by upregulating STIM1\/Orai1 via activation of Akt\/mTOR in human pulmonary arterial smooth muscle cells. Am J Physiol Cell Physiol 302(2):C405\u2013C411","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"17_CR0017139","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.ejcts.2004.08.031","volume":"26","author":"M Ono","year":"2004","unstructured":"Ono M, Sawa Y et al (2004a) Gene transfer of hepatocyte growth factor with prostacyclin synthase in severe pulmonary hypertension of rats. Eur J Cardiothorac Surg 26(6):1092\u20131097","journal-title":"Eur J Cardiothorac Surg"},{"issue":"18","key":"17_CR0017140","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1161\/01.CIR.0000146342.30470.30","volume":"110","author":"M Ono","year":"2004","unstructured":"Ono M, Sawa Y et al (2004b) Hepatocyte growth factor suppresses vascular medial hyperplasia and matrix accumulation in advanced pulmonary hypertension of rats. Circulation 110(18):2896\u20132902","journal-title":"Circulation"},{"issue":"12","key":"17_CR0017141","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1248\/bpb.23.1517","volume":"23","author":"JS Park","year":"2000","unstructured":"Park JS, Kim JY et al (2000) Epidermal growth factor (EGF) antagonizes transforming growth factor (TGF)-beta1-induced collagen lattice contraction by human skin fibroblasts. Biol Pharm Bull 23(12):1517\u20131520","journal-title":"Biol Pharm Bull"},{"issue":"6 Pt 2","key":"17_CR0017142","first-page":"H1948","volume":"275","author":"C Partovian","year":"1998","unstructured":"Partovian C, Adnot S et al (1998) Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. Am J Physiol 275(6 Pt 2):H1948\u2013H1956","journal-title":"Am J Physiol"},{"issue":"6","key":"17_CR0017143","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1165\/ajrcmb.23.6.4106","volume":"23","author":"C Partovian","year":"2000","unstructured":"Partovian C, Adnot S et al (2000) Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am J Respir Cell Mol Biol 23(6):762\u2013771","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11","key":"17_CR0017144","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.110.963314","volume":"123","author":"R Paulin","year":"2011","unstructured":"Paulin R, Courboulin A et al (2011a) Signal transducers and activators of transcription-3\/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension. Circulation 123(11):1205\u20131215","journal-title":"Circulation"},{"issue":"5","key":"17_CR0017145","doi-asserted-by":"publisher","first-page":"H1798","DOI":"10.1152\/ajpheart.00654.2011","volume":"301","author":"R Paulin","year":"2011","unstructured":"Paulin R, Meloche J et al (2011b) Dehydroepiandrosterone inhibits the Src\/STAT3 constitutive activation in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 301(5):H1798\u2013H1809","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"17_CR0017146","doi-asserted-by":"publisher","first-page":"e12106","DOI":"10.1371\/journal.pone.0012106","volume":"5","author":"SA Pendergrass","year":"2010","unstructured":"Pendergrass SA, Hayes E et al (2010) Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. PLoS One 5(8):e12106","journal-title":"PLoS One"},{"issue":"1","key":"17_CR0017147","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1164\/rccm.200707-1037OC","volume":"178","author":"F Perros","year":"2008","unstructured":"Perros F, Montani D et al (2008) Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178(1):81\u201388","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"17_CR0017148","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1164\/rccm.201105-0927OC","volume":"185","author":"F Perros","year":"2012","unstructured":"Perros F, Dorfmuller P et al (2012) Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 185(3):311\u2013321","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"17_CR0017149","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1378\/chest.11-0793","volume":"141","author":"LC Price","year":"2012","unstructured":"Price LC, Wort SJ et al (2012) Inflammation in pulmonary arterial hypertension. Chest 141(1):210\u2013221","journal-title":"Chest"},{"issue":"4","key":"17_CR0017150","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/1947601911409738","volume":"2","author":"AM Puzio-Kuter","year":"2011","unstructured":"Puzio-Kuter AM (2011) The role of p53 in metabolic regulation. Genes Cancer 2(4):385\u2013391","journal-title":"Genes Cancer"},{"issue":"5","key":"17_CR0017151","doi-asserted-by":"crossref","first-page":"L897","DOI":"10.1152\/ajplung.00044.2001","volume":"282","author":"TP Quinn","year":"2002","unstructured":"Quinn TP, Schlueter M et al (2002) Cyclic mechanical stretch induces VEGF and FGF-2 expression in pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 282(5):L897\u2013L903","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1 Pt 1","key":"17_CR0017152","first-page":"L5","volume":"277","author":"M Rabinovitch","year":"1999","unstructured":"Rabinovitch M (1999) EVE and beyond, retro and prospective insights. Am J Physiol 277(1 Pt 1):L5\u2013L12","journal-title":"Am J Physiol"},{"issue":"3","key":"17_CR0017153","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0272-5231(05)70282-3","volume":"22","author":"M Rabinovitch","year":"2001","unstructured":"Rabinovitch M (2001) Pathobiology of pulmonary hypertension. Extracellular matrix. Clin Chest Med 22(3):433\u2013449, viii","journal-title":"Clin Chest Med"},{"issue":"6 Suppl","key":"17_CR0017154","doi-asserted-by":"publisher","first-page":"642S","DOI":"10.1378\/chest.128.6_suppl.642S","volume":"128","author":"M Rabinovitch","year":"2005","unstructured":"Rabinovitch M (2005) Cellular and molecular pathobiology of pulmonary hypertension conference summary. Chest 128(6 Suppl):642S\u2013646S","journal-title":"Chest"},{"issue":"2","key":"17_CR0017155","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12013-011-9332-z","volume":"67","author":"Yazhini Ravi","year":"2011","unstructured":"Ravi Y, Selvendiran K et al (2011) Dysregulation of PTEN in cardiopulmonary vascular remodeling induced by pulmonary hypertension. Cell Biochem Biophys. doi:10.1007\/s12013-011-9332-z","journal-title":"Cell Biochemistry and Biophysics"},{"issue":"3","key":"17_CR0017156","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1113\/expphysiol.2007.040469","volume":"93","author":"L Ray","year":"2008","unstructured":"Ray L, Mathieu M et al (2008) Early increase in pulmonary vascular reactivity with overexpression of endothelin-1 and vascular endothelial growth factor in canine experimental heart failure. Exp Physiol 93(3):434\u2013442","journal-title":"Exp Physiol"},{"issue":"3","key":"17_CR0017157","doi-asserted-by":"publisher","first-page":"L486","DOI":"10.1152\/ajplung.00237.2010","volume":"300","author":"W Ren","year":"2011","unstructured":"Ren W, Watts SW et al (2011) Serotonin transporter interacts with the PDGFbeta receptor in PDGF-BB-induced signaling and mitogenesis in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 300(3):L486\u2013L497","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"17_CR0017158","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1183\/09031936.00187310","volume":"39","author":"AM Reynolds","year":"2012","unstructured":"Reynolds AM, Holmes MD et al (2012) Targeted gene delivery of BMPR2 attenuates pulmonary hypertension. Eur Respir J 39(2):329\u2013343","journal-title":"Eur Respir J"},{"issue":"9","key":"17_CR0017159","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1161\/01.CIR.0000053443.27512.33","volume":"107","author":"B Rondelet","year":"2003","unstructured":"Rondelet B, Kerbaul F et al (2003) Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 107(9):1329\u20131335","journal-title":"Circulation"},{"issue":"1","key":"17_CR0017160","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1006\/jmcc.2000.1272","volume":"33","author":"Y Saito","year":"2001","unstructured":"Saito Y, Berk BC (2001) Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J Mol Cell Cardiol 33(1):3\u20137","journal-title":"J Mol Cell Cardiol"},{"key":"17_CR0017161","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1465-9921-12-17","volume":"12","author":"M Sands","year":"2011","unstructured":"Sands M, Howell K et al (2011) Placenta growth factor and vascular endothelial growth factor B expression in the hypoxic lung. Respir Res 12:17","journal-title":"Respir Res"},{"issue":"4 Pt 1","key":"17_CR0017162","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1164\/ajrccm\/145.4_Pt_1.793","volume":"145","author":"K Sato","year":"1992","unstructured":"Sato K, Webb S et al (1992) Factors influencing the idiopathic development of pulmonary hypertension in the fawn hooded rat. Am Rev Respir Dis 145(4 Pt 1):793\u2013797","journal-title":"Am Rev Respir Dis"},{"key":"17_CR0017163","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1465-9921-10-6","volume":"10","author":"L Savale","year":"2009","unstructured":"Savale L, Tu L et al (2009) Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res 10:6","journal-title":"Respir Res"},{"issue":"10","key":"17_CR0017164","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1172\/JCI24838","volume":"115","author":"RT Schermuly","year":"2005","unstructured":"Schermuly RT, Dony E et al (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115(10):2811\u20132821","journal-title":"J Clin Invest"},{"issue":"35","key":"17_CR0017165","doi-asserted-by":"publisher","first-page":"33045","DOI":"10.1074\/jbc.M100798200","volume":"276","author":"M Shang","year":"2001","unstructured":"Shang M, Koshikawa N et al (2001) The LG3 module of laminin-5 harbors a binding site for integrin alpha3beta1 that promotes cell adhesion, spreading, and migration. J Biol Chem 276(35):33045\u201333053","journal-title":"J Biol Chem"},{"issue":"9","key":"17_CR0017166","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","volume":"122","author":"E Soon","year":"2010","unstructured":"Soon E, Holmes AM et al (2010) Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 122(9):920\u2013927","journal-title":"Circulation"},{"issue":"2","key":"17_CR0017167","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1161\/CIRCRESAHA.108.182014","volume":"104","author":"MK Steiner","year":"2009","unstructured":"Steiner MK, Syrkina OL et al (2009) Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 104(2):236\u2013244, 228p following 244","journal-title":"Circ Res"},{"issue":"21","key":"17_CR0017168","doi-asserted-by":"publisher","first-page":"12331","DOI":"10.1073\/pnas.1933740100","volume":"100","author":"CC Sullivan","year":"2003","unstructured":"Sullivan CC, Du L et al (2003) Induction of pulmonary hypertension by an angiopoietin 1\/TIE2\/serotonin pathway. Proc Natl Acad Sci USA 100(21):12331\u201312336","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"17_CR0017169","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1182\/blood-2009-09-244830","volume":"116","author":"N Sundaram","year":"2010","unstructured":"Sundaram N, Tailor A et al (2010) High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension. Blood 116(1):109\u2013112","journal-title":"Blood"},{"issue":"44","key":"17_CR0017170","doi-asserted-by":"publisher","first-page":"44ra58","DOI":"10.1126\/scitranslmed.3001327","volume":"2","author":"G Sutendra","year":"2010","unstructured":"Sutendra G, Bonnet S et al (2010) Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension. Sci Transl Med 2(44):44ra58","journal-title":"Sci Transl Med"},{"issue":"3","key":"17_CR0017171","doi-asserted-by":"publisher","first-page":"L450","DOI":"10.1152\/ajplung.00206.2005","volume":"290","author":"H Takahashi","year":"2006","unstructured":"Takahashi H, Goto N et al (2006) Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 290(3):L450\u2013L458","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"17_CR0017172","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/thx.2004.029082","volume":"60","author":"MC Tamby","year":"2005","unstructured":"Tamby MC, Chanseaud Y et al (2005) Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 60(9):765\u2013772","journal-title":"Thorax"},{"issue":"8","key":"17_CR0017173","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/CIRCRESAHA.110.236927","volume":"109","author":"R Tamosiuniene","year":"2011","unstructured":"Tamosiuniene R, Tian W et al (2011) Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension. Circ Res 109(8):867\u2013879","journal-title":"Circ Res"},{"issue":"1\u20132","key":"17_CR0017174","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1023\/A:1026506801659","volume":"215","author":"Y Tanabe","year":"2000","unstructured":"Tanabe Y, Saito M et al (2000) Mechanical stretch augments PDGF receptor beta expression and protein tyrosine phosphorylation in pulmonary artery tissue and smooth muscle cells. Mol Cell Biochem 215(1\u20132):103\u2013113","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"17_CR0017175","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1096\/fj.00-0343com","volume":"15","author":"L Taraseviciene-Stewart","year":"2001","unstructured":"Taraseviciene-Stewart L, Kasahara Y et al (2001) Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 15(2):427\u2013438","journal-title":"FASEB J"},{"issue":"2","key":"17_CR0017176","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/01.RES.0000200180.01710.e6","volume":"98","author":"K Teichert-Kuliszewska","year":"2006","unstructured":"Teichert-Kuliszewska K, Kutryk MJ et al (2006) Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 98(2):209\u2013217","journal-title":"Circ Res"},{"issue":"10","key":"17_CR0017177","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1164\/rccm.200707-1015OC","volume":"177","author":"B Terrier","year":"2008","unstructured":"Terrier B, Tamby MC et al (2008) Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension. Am J Respir Crit Care Med 177(10):1128\u20131134","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"17_CR0017178","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/(SICI)1097-4652(199603)166:3<495::AID-JCP4>3.0.CO;2-K","volume":"166","author":"K Thompson","year":"1996","unstructured":"Thompson K, Rabinovitch M (1996) Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor. J Cell Physiol 166(3):495\u2013505","journal-title":"J Cell Physiol"},{"issue":"1","key":"17_CR0017179","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1152\/physiolgenomics.00094.2009","volume":"40","author":"J Tian","year":"2009","unstructured":"Tian J, Smith A et al (2009) Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension. Physiol Genomics 40(1):48\u201360","journal-title":"Physiol Genomics"},{"issue":"2","key":"17_CR0017180","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1165\/rcmb.2010-0317OC","volume":"45","author":"L Tu","year":"2011","unstructured":"Tu L, Dewachter L et al (2011) Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension. Am J Respir Cell Mol Biol 45(2):311\u2013322","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"7","key":"17_CR0017181","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1164\/rccm.201202-0309OC","volume":"186","author":"L Tu","year":"2012","unstructured":"Tu L, de Man FS et al (2012) A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodent. Am J Respir Crit Care Med 186(7):666\u2013676","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"17_CR0017182","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/path.953","volume":"195","author":"RM Tuder","year":"2001","unstructured":"Tuder RM, Chacon M et al (2001) Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 195(3):367\u2013374","journal-title":"J Pathol"},{"issue":"18","key":"17_CR0017183","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1038\/sj.onc.1210915","volume":"27","author":"S Uttamsingh","year":"2008","unstructured":"Uttamsingh S, Bao X et al (2008) Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 27(18):2626\u20132634","journal-title":"Oncogene"},{"issue":"Suppl 5","key":"17_CR0017184","first-page":"S6","volume":"17","author":"PM Vanhoutte","year":"1991","unstructured":"Vanhoutte PM (1991) Platelet-derived serotonin, the endothelium, and cardiovascular disease. J Cardiovasc Pharmacol 17(Suppl 5):S6\u2013S12","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"17_CR0017185","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/01.RES.87.5.418","volume":"87","author":"A Vieillard-Baron","year":"2000","unstructured":"Vieillard-Baron A, Frisdal E et al (2000) Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats. Circ Res 87(5):418\u2013425","journal-title":"Circ Res"},{"issue":"9","key":"17_CR0017186","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1089\/104303403765701150","volume":"14","author":"A Vieillard-Baron","year":"2003","unstructured":"Vieillard-Baron A, Frisdal E et al (2003) Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer limits monocrotaline-induced pulmonary vascular remodeling in rats. Hum Gene Ther 14(9):861\u2013869","journal-title":"Hum Gene Ther"},{"issue":"2","key":"17_CR0017187","doi-asserted-by":"publisher","first-page":"L209","DOI":"10.1152\/ajplung.00185.2005","volume":"290","author":"NF Voelkel","year":"2006","unstructured":"Voelkel NF, Vandivier RW et al (2006) Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 290(2):L209\u2013L221","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"17_CR0017188","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1440-1681.2011.05516.x","volume":"38","author":"Y Wang","year":"2011","unstructured":"Wang Y, Han DD et al (2011) Downregulation of osteopontin is associated with fluoxetine amelioration of monocrotaline-induced pulmonary inflammation and vascular remodelling. Clin Exp Pharmacol Physiol 38(6):365\u2013372","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"17_CR0017189","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1203\/01.pdr.0000250013.77008.28","volume":"61","author":"S Wedgwood","year":"2007","unstructured":"Wedgwood S, Devol JM et al (2007) Fibroblast growth factor-2 expression is altered in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 61(1):32\u201336","journal-title":"Pediatr Res"},{"issue":"12","key":"17_CR0017190","doi-asserted-by":"publisher","first-page":"L1273","DOI":"10.1152\/ajplung.00082.2012","volume":"302","author":"L Wei","year":"2012","unstructured":"Wei L, Warburton R et al (2012) Serotonylated fibronectin is elevated in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 302(12):L1273\u2013L1279","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"17_CR0017191","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0014-5793(97)01481-6","volume":"420","author":"C Wheeler-Jones","year":"1997","unstructured":"Wheeler-Jones C, Abu-Ghazaleh R et al (1997) Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42\/p44 mitogen-activated protein kinase. FEBS Lett 420(1):28\u201332","journal-title":"FEBS Lett"},{"issue":"3","key":"17_CR0017192","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","volume":"124","author":"S Wullschleger","year":"2006","unstructured":"Wullschleger S, Loewith R et al (2006) TOR signaling in growth and metabolism. Cell 124(3):471\u2013484","journal-title":"Cell"},{"issue":"5","key":"17_CR0017193","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1083\/jcb.200103111","volume":"154","author":"J Xu","year":"2001","unstructured":"Xu J, Rodriguez D et al (2001) Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 154(5):1069\u20131079","journal-title":"J Cell Biol"},{"issue":"4","key":"17_CR0017194","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1073\/pnas.0605080104","volume":"104","author":"W Xu","year":"2007","unstructured":"Xu W, Koeck T et al (2007) Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci USA 104(4):1342\u20131347","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"17_CR0017195","doi-asserted-by":"crossref","first-page":"C1680","DOI":"10.1152\/ajpcell.2001.280.6.C1680","volume":"280","author":"IA Yamboliev","year":"2001","unstructured":"Yamboliev IA, Gerthoffer WT (2001) Modulatory role of ERK MAPK-caldesmon pathway in PDGF-stimulated migration of cultured pulmonary artery SMCs. Am J Physiol Cell Physiol 280(6):C1680\u2013C1688","journal-title":"Am J Physiol Cell Physiol"},{"issue":"10","key":"17_CR0017196","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/01.RES.0000166926.54293.68","volume":"96","author":"X Yang","year":"2005","unstructured":"Yang X, Long L et al (2005) Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ Res 96(10):1053\u20131063","journal-title":"Circ Res"},{"issue":"4","key":"17_CR0017197","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/hc0402.102866","volume":"105","author":"SH Zaidi","year":"2002","unstructured":"Zaidi SH, You XM et al (2002) Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension. Circulation 105(4):516\u2013521","journal-title":"Circulation"},{"issue":"8","key":"17_CR0017198","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1440-1681.2009.05168.x","volume":"36","author":"FG Zhai","year":"2009","unstructured":"Zhai FG, Zhang XH et al (2009) Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats. Clin Exp Pharmacol Physiol 36(8):850\u2013856","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"17_CR0017199","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1440-1681.2009.05181.x","volume":"36","author":"SP Zhu","year":"2009","unstructured":"Zhu SP, Mao ZF et al (2009) Continuous fluoxetine administration prevents recurrence of pulmonary arterial hypertension and prolongs survival in rats. Clin Exp Pharmacol Physiol 36(8):e1\u2013e5","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Handbook of Experimental Pharmacology","Pharmacotherapy of Pulmonary Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-38664-0_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T07:43:55Z","timestamp":1749023035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-38664-0_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9783642386633","9783642386640"],"references-count":200,"aliases":["10.1007\/978-3-662-45805-1_17"],"URL":"https:\/\/doi.org\/10.1007\/978-3-642-38664-0_17","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"6 August 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}